[Deaf Smith]

Never figured out how copy ‘n paste on a phone.

Search bar: nih.gov ivermectin cancer

That will get you to the research and papers.

[Norski]

Thank you.

“Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy”

https://pmc.ncbi.nlm.nih.gov/articles/PMC11008553/

Several excerpts:

” . . .Emerging literature highlights the potential use of ivermectin as a promising candidate for anticancer therapy [26-29]. Several studies have addressed its antiviral activity against a diverse range of viruses, leading to its exploration for use in treating SARS-CoV-2 during the most recent global pandemic [30]...”.

” . . .Anti-inflammatory activity

The role of ivermectin as an anti-inflammatory agent has only recently been understood. This is an integral part of its use as an antihelminthic agent. Ivermectin is now known to play an immunomodulatory role that suppresses inflammatory responses in humans [48]. “ . . .

” . . .Rosacea

Rosacea is a chronic, progressive, inflammatory skin condition. With a prevalence of almost 5.5%, it is a disorder that can cause a great disease burden, including its impact on self-esteem and the quality of life of affected individuals [53].” . .

” . . .SARS-CoV-2

In the context of the most recent pandemic, ivermectin garnered significant attention due to its potential therapeutic implications in the management of COVID-19. Its mode of action in the treatment of COVID-19 is based on the fact that ivermectin can inhibit viral protein transportation through IMP-α/β1 [57]. In addition, the anti-inflammatory characteristic of ivermectin may explain its potential impact on infectious agents such as COVID-19. A cytokine storm in severe COVID-19 has been described, which involves STAT-3 upregulation of proinflammatory cytokines [50]. Ivermectin has been shown to inhibit STAT-3, so it may help treat severe cases of COVID-19. In vitro studies of ivermectin have demonstrated that it kills SARS-CoV-2 in 48 hours [30].” . .

” . . .Anticancer activity

The versatility of ivermectin continues to unfold, with much research on its role as a potential anticancer drug. It is postulated that ivermectin can inhibit tumorigenic cell proliferation through various pathways. Researchers first noted the anticancer effects of ivermectin in 2015 through its ability to induce autophagy in cancer cells [66]. “ . . .

“